Data / Form D filings / Organogenesis Holdings Inc.
Organogenesis Holdings Inc.: Form D filing
Organogenesis Holdings Inc., a biotechnology company in Canton, MA, filed a Form D with the SEC in 2024. The latest, on November 27, 2024, reports $130 million sold of a $130 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 85 DAN ROAD, Canton, MA, 02021
- Phone
- (781) 575-0775
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1661181
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | New notice | $130,000,000 | $130,000,000 | 2 | Nov 12, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michele S. Korfin | Director | |
| Michael J. Driscoll | Director | |
| Antonio C. Montecalvo | Executive Officer | |
| Jon J. Giacomin | Director | |
| Prathyusha J. Duraibabu | Director | |
| Arthur S. Leibowitz | Director | |
| Robert A. Ades | Director | |
| Patrick H. Bilbo | Executive Officer | |
| Robert C. Cavorsi | Executive Officer | |
| Gary S. Gillheeney, Sr. | Executive Officer, Director | |
| Alan A. Ades | Director | |
| Lori C. Freedman | Executive Officer | |
| David C. Francisco | Executive Officer | |
| David J. Erani | Director | |
| Glenn H. Nussdorf | Director | |
| Garrett C. Lustig | Director | |
| Gilberto H. Quintero | Director | |
| Brian C. Grow | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Nov 25, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Organogenesis Holdings Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.